SEB Asset Management AB »

Upstream Bio shares owned by SEB Asset Management AB

Quarter-by-quarter ownership of Upstream Bio (UPB) shares owned by SEB Asset Management AB from 13F filings

Historical chart of SEB Asset Management AB investment in Upstream Bio

Tip: Access up to 7 years of quarterly data

All positions including Upstream Bio held by SEB Asset Management AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Upstream Bio by SEB Asset Management AB

Quarter filed Position value Share count Share price at filing
2026-03-31 $7.9M 879k 9.00

More positions owned by SEB Asset Management AB

NVIDIA Corporation (NVDA)
Apple (AAPL)
Astrazeneca Ord (AZN)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Johnson & Johnson (JNJ)
Mastercard Incorporated Cl A (MA)
Citigroup Com New (C)
Tesla Motors (TSLA)

View all positions for SEB Asset Management AB

Top funds holding Upstream Bio

FMR
OrbiMed Advisors
BlackRock
Decheng Capital
Enavate Sciences GP
Vanguard Group
Vanguard Capital Management
Omega Fund Management
State Street Corporation
Y-Intercept
Federated Investors
Geode Capital Management
Millennium Management
Wellington Management Company
SEB Asset Management AB

View all funds holding Upstream Bio